Scribe Therapeutics
Portfolio of genetic medicines for cardiometabolic disease using proprietary, engineered gene editing and epigenetic silencing platforms
Portfolio of genetic medicines for cardiometabolic disease using proprietary, engineered gene editing and epigenetic silencing platforms